Cargando…
Risk stratification tools in prostate cancer, where do we stand?
Autores principales: | Clinckaert, Andries, Devos, Gaëtan, Roussel, Eduard, Joniau, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844509/ https://www.ncbi.nlm.nih.gov/pubmed/33532290 http://dx.doi.org/10.21037/tau-20-1211 |
Ejemplares similares
-
PREDICT Prostate, a useful tool in men with low- and intermediate-risk prostate cancer who are hesitant between conservative management and active treatment
por: Devos, Gaëtan, et al.
Publicado: (2020) -
Topical therapy of psoriasis: Where do we stand?
por: Thappa, DM, et al.
Publicado: (2017) -
Mechanical Thrombectomy- Where Do We Stand Now ?
por: Chakraborty, Debabrata, et al.
Publicado: (2022) -
Surgical trials in India, where do we stand?
por: Khajanchi, M
Publicado: (2022) -
Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005)